Related Experiment Video
Updated: Feb 14, 2026

Harvesting Solar Energy by Means of Charge-Separating Nanocrystals and Their Solids
Published on: August 23, 2012
Enhanced Drug Photosafety by Interchromophoric Interaction Owing to Intramolecular Charge Separation
Ming-De Li1, Zhiping Yan2, Ruixue Zhu2
1Department of Chemistry and Key Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province, Shantou University, Guangdong, 515063, P. R. China.
Abstract:
Imatinib is a synthetic tyrosinase inhibitor that is employed for the treatment of some kinds of human cancer. This drug has a low phototoxicity towards DNA, but its pyridylpyrimidine (1) fragment by itself exhibits significant phototoxicitiy. The intrinsic mechanism that leads to the enhanced photosafety of Imatinib is not yet known. Here, the properties of the excited state and interchromophoric interactions of Imatinib have been explored by using ultrafast laser flash photolysis and agarose electrophoresis studies. An intramolecular charge separation was directly observed for the irradiated Imatinib, which accounts for the relaxation of its excited state. An anionic form of pyridylpyrimidine (1) was deduced from the results of time-resolved resonance Raman spectra and by quenching experimental studies on compound 1 and diaminotoluene. In contrast, compound 1 efficiently transformed into triplet excited states with a long lifetime, which explained the phototoxicity associated with this fragment. This work provides insight into how to design drugs with lower phototoxicitiy or improved photostability by using interchromophoric interactions.
Insights
Imatinib, a cancer drug, shows low phototoxicity due to intramolecular charge separation. Its pyridylpyrimidine fragment is phototoxic, highlighting the role of interchromophoric interactions in drug photosafety.
Area of Science:
- Photochemistry
- Medicinal Chemistry
- Molecular Biophysics
Background:
- Imatinib is a cancer therapeutic with low DNA phototoxicity.
- The pyridylpyrimidine fragment of imatinib exhibits significant phototoxicity.
- The mechanism behind imatinib's enhanced photosafety is not well understood.
Purpose of the Study:
- To investigate the excited state properties and interchromophoric interactions of imatinib.
- To elucidate the mechanism of imatinib's photosafety.
- To understand the phototoxicity of the pyridylpyrimidine fragment.
Main Methods:
- Ultrafast laser flash photolysis.
- Agarose electrophoresis.
- Time-resolved resonance Raman spectroscopy.
- Quenching studies.
Main Results:
- Direct observation of intramolecular charge separation in irradiated imatinib, facilitating excited state relaxation.
- Identification of an anionic form of the pyridylpyrimidine fragment.
- Pyridylpyrimidine efficiently forms long-lived triplet excited states, correlating with its phototoxicity.
Conclusions:
- Intramolecular charge separation contributes to imatinib's photosafety.
- Interchromophoric interactions are crucial for modulating drug phototoxicity.
- This study offers insights for designing safer or more photostable drugs.
Related Concept Videos
Intermolecular vs Intramolecular Forces
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions

